 |
|
The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors
Ki-Yong An, Woo-Jin Shin, Kyu-Jung Lee
J Bone Metab. 2013;20(2):95-98. Published online 2013 Nov 18 DOI: https://doi.org/10.11005/jbm.2013.20.2.95
|
|
Citations to this article as recorded by
 The use of antidepressants is linked to bone loss: A systematic review and metanalysis
Michele Mercurio, Renato de Filippis, Giovanna Spina, Pasquale De Fazio, Cristina Segura-Garcia, Olimpio Galasso, Giorgio Gasparini
Orthopedic Reviews.2022;[Epub] CrossRef Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
C. Zhou, L. Fang, Y. Chen, J. Zhong, H. Wang, P. Xie
Osteoporosis International.2018; 29(6): 1243. CrossRef The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite – 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease
Dariusz Pawlak, Ewa Oksztulska-Kolanek, Beata Znorko, Tomasz Domaniewski, Joanna Rogalska, Alicja Roszczenko, Małgorzata Michalina Brzóska, Anna Pryczynicz, Andrzej Kemona, Krystyna Pawlak, Luc Malaval
PLOS ONE.2016; 11(10): e0163526. CrossRef Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system
Tadeusz Niedźwiedzki, Joanna Filipowska
Journal of Molecular Endocrinology.2015; 55(2): R23. CrossRef
|